Table 3.

Risk of HF by Age, Sex, and Race/Ethnicity^a

	Events/No. at Risk	Model 1, HR (95% CI)b	P Value	Model 2, HR (95% CI)c	P Value	Interaction P Valued
Age, ye						0.56
<61	45/2979	1.19 (0.75‐1.89)	0.47	1.30 (0.82‐2.06)	0.27
≥61	172/3415	1.32 (1.05‐1.67)	0.017	1.37 (1.08‐1.73)	0.0087
Sex						0.14
M	127/2958	1.50 (1.15‐1.96)	0.0028	1.61 (1.23‐2.12)	0.0006
F	90/3436	1.16 (0.84‐1.60)	0.37	1.20 (0.86‐1.67)	0.27
Race/ethnicity						0.69
White	87/2413	1.27 (0.92‐1.75)	0.14	1.32 (0.95‐1.81)	0.095
Nonwhite	130/3981	1.41 (1.08‐1.84)	0.011	1.45 (1.10‐1.90)	0.0079

Abbreviations: BMI, body mass index; CI, confidence interval; DM, diabetes mellitus; F, female; HDL‐C, high‐density lipoprotein cholesterol; HF, heart failure; HR, hazard ratio; ID, intrinsicoid deflection; LVH, left ventricular hypertrophy; M, male; ms, millisecond; SBP, systolic blood pressure.

^a HR presented for maximum time to ID per 10‐ms increase.

^b Adjusted for age, sex, race/ethnicity, education, and income.

^c Adjusted for Model 1 covariates plus heart rate, SBP, smoking, DM, BMI, cholesterol, HDL‐C, aspirin, statins, antihypertensive medications, and LVH.

^d Interactions tested using Model 2.

^e Stratified by the median age for study participants.